News . Data . Research
ANI Pharmaceuticals Inc (NASDAQ:ANIP) Q4 2022 Earnings Call dated Mar. 09, 2023. Corporate Participants: Judy DiClemente -- Investor Relations Nikhil Lalwani -- President and Chief Executive
Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) released details of discoveries that have potential applications for tumor suppression across multiple cancer pathways.
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Q4 2022 Earnings Call dated Mar. 01, 2023. Corporate Participants: Darren Fox -- Executive Director, Investor Relations Bruce C. Cozadd -- Chairman
Agilent Technologies (NYSE: A) has announced first-quarter 2023 financial results, reporting an increase in adjusted profit and revenues. The Santa Clara, California-based
Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said its scientific co-founder Dr. Jonathan Kurtis received a new patent for his discovery related
BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Q4 2022 Earnings Call dated Feb. 27, 2023. Corporate Participants: Traci McCarty -- Group Vice President of Investor Relations Jean-Jacques
The global pharmaceutical market is expected to cross $1.5 trillion this year, which represents a 4-5% annual growth over the past five
Zoetis Inc (NYSE: ZTS) Q4 2022 earnings call dated Feb. 14, 2023 Corporate Participants: Steve Frank -- Vice President, Investor Relations Kristin Peck -- Chief Executive
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported total revenues of $2.3 billion for the fourth quarter of 2022. This compares to $2 billion in
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q4 2022 earnings call dated Feb. 03, 2023 Corporate Participants: Ryan Crowe -- Vice President, Investor Relations Leonard S.
Cigna Corporation (NYSE: CI) has reported an increase in net income for the fourth quarter of 2022 when the healthcare services provider's
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) has reported a sharp increase in net profit for the fourth quarter of 2022 when
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Friday reported a sharp fall in fourth-quarter revenues and adjusted earnings. Total revenues plunged 31% year-over-year
Eli Lilly and Company (NYSE: LLY) Q4 2022 earnings call dated Feb. 02, 2023 Corporate Participants: Joe Fletcher -- Senior Vice President of Investor
Eli Lilly and Company (NYSE: LLY) reported fourth quarter 2022 earnings results today. Revenue fell 9% year-over-year to $7.3 billion. Reported net income
Quest Diagnostics Incorporated (NYSE: DGX) has announced financial results for the fourth quarter of 2022, reporting a sharp decline in adjusted profit
Bristol Myers Squibb (NYSE: BMY) on Thursday announced results for the fourth quarter of 2022, reporting lower earnings and revenues. The pharma
Humana Inc. (NYSE: HUM) on Wednesday reported fourth-quarter 2022 results. Adjusted profit increased from last year, aided by a 7% growth in
Medical device maker Boston Scientific Corporation (NYSE: BSX) has announced financial results for the fourth quarter of 2022, reporting a decline in
Shares of Pfizer Inc. (NYSE: PFE) were up on Tuesday despite the company delivering mixed results for the fourth quarter of 2022
Pfizer Inc. (NYSE: PFE) reported fourth quarter 2022 earnings results today. Revenues increased 2% year-over-year to $24.3 billion but missed estimates. Reported